Top

News
  • スライド1
  • スライド1
  • スライド1

Change the future
with cell therapy

Our aim is to develop new cell therapies
using “hematopoietic stem cells”.

Hematopoietic stem cells (HSCs) are the stem cells that are the very source of blood.
Our aim is to develop new cell therapies in order to treat blood cancer,
intractable blood diseases and genetic disorders.

The development of new cell therapies  in the fight against leukemia and other blood cancers and genetic disorders
Our goals

The development of new cell therapies in the fight against leukemia and other blood cancers and genetic disorders

We are working on the development of next-generation cell therapy products that will utilize the unique properties of umbilical cord blood and peripheral blood, by expanding them in large quantities.

体外での増殖が困難な造血幹細胞の増殖に成功
Our technologies

Successful in-vitro expansion of functional hematopoietic stem cells

We have succeeded in developing technology for the mass propagation of functional HSCs with blood reconstruction ability. In addition, since the technology does not use animal-derived components such as albumin and cytokines, HSCs can be propagated in large quantities with high quality and at low cost.

高まる造血幹細胞移植ニーズと造血幹細胞移植に求められるイノベーション
About hematopoietic stem cells

A growing need for the application of HSCs in cell therapy

In addition to providing new therapeutic options for the HSC transplantation treatments that are being performed today, we are also working on applications in the field of gene therapy, which has seen much active development in recent years.

Copyright© セレイド セラピューティクス / Celaid Therapeutics , 2021 All Rights Reserved Powered by STINGER.